One-Year Transcutaneous Tibial Nerve Stimulation Treatment Persistence in Lower Urinary Tract Dysfunction: Clinical and Urodynamic Associated Factors in a Prospective Observational Study
Listen to this summary
The authors aimed to assess the persistence of Transcutaneous Tibial Nerve Stimulation (TTNS) treatment over one year in patients with lower urinary tract dysfunction (LUTD) and to identify clinical and urodynamic factors influencing this persistence. Their findings revealed that 38% of patients continued treatment after one year, with higher persistence rates observed in patients with neurological LUTD compared to non-neurological cases. Additionally, early patient-reported outcomes and symptom burden were significant predictors of long-term treatment adherence, suggesting the need for further research on the relationship between neuro-urological profiles and TTNS persistence.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from Neurourology and urodynamics
View all →Aug 10, 2026 · Neurourology and urodynamics
Retrospective Evaluation of Contemporary Complication Rates and Severity After Suprapubic Tube Placement by Urology and Interventional Radiology
Aug 10, 2026 · Neurourology and urodynamics
Restoring Continence After Devastating Post-Obstetric Fistula Repair Incontinence: A Pilot Study Comparing Cystoscopic vs Periurethral Bulkamid
Aug 10, 2026 · Neurourology and urodynamics
The Acute Effect of Daily Caffeine Intake on Urination Parameters in Men With Lower Urinary Tract Symptoms
Aug 7, 2026 · Neurourology and urodynamics
Institutional Outcomes of Immediate vs Delayed or No Clean Intermittent Catheterization in Infant Neurogenic Bladder
Aug 7, 2026 · Neurourology and urodynamics
Sarcopenia and Female Lower Urinary Tract Symptoms: A Systematic Review
Aug 6, 2026 · Neurourology and urodynamics
Diabetes-Induced Dysregulation of Purinergic Signaling in the Bladder Mucosa: Accelerated ATP Hydrolysis and Impaired Adenosine Uptake Promote Underactive Bladder Phenotype
More in Urology
View all →Aug 7, 2026 · International urogynecology journal
Multimodal Biomarker and Ultrasound Profiling in Women with Overactive Bladder: A Prospective Case-Control Study
Aug 7, 2026 · Journal of lower genital tract disease
Extended HPV Genotyping for Risk Stratification in Cervical Screening: A Population-based Study
Aug 7, 2026 · Journal of lower genital tract disease
Comparison of Colorimetric LAMP and PCR for High-risk HPV Detection: Implications for Cervical Cancer Screening
Aug 6, 2026 · JAMA
Iron or Multiple Micronutrient Powder Supplements With Malaria Chemoprevention in Rural Malawian Children: The IRMA Randomized Clinical Trial
Aug 6, 2026 · Lancet (London, England)
[<sup>177</sup>Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial
Aug 5, 2026 · JAMA
Duration of Therapeutic Hypothermia After Out-of-Hospital Cardiac Arrest: The ICECAP Randomized Clinical Trial
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


